cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Agilent Technologies Inc
17 own
28 watching
Current Price
$154.42
$-0.09
(-0.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
45,593.89M
52-Week High
52-Week High
160.265
52-Week Low
52-Week Low
112.52
Average Volume
Average Volume
1.07M
Dividend Yield
Dividend Yield
0.004961
P/E Ratio
P/E Ratio
67.8719
iconMarket Capitalization45,593.89M
icon52-Week High160.265
icon52-Week Low112.52
iconAverage Volume1.07M
iconDividend Yield0.004961
iconP/E Ratio67.8719
What does the Agilent Technologies Inc do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The company's Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets and sells its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has a collaboration agreement with University of Leuven to focus on detecting genetic abnormalities in cell-free DNA and embryo biopsies. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Read More
How much money does Agilent Technologies Inc make?
News & Events about Agilent Technologies Inc.
Business Wire
1month ago
Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the companys high-quality active pharmaceutical ingredients (API...
Business Wire
1month ago
Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the...
Business Wire
1month ago
Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to study...
Business Wire
1month ago
Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment...
Business Wire
2 months ago
Agilent Technologies Inc. (NYSE: A) today announced the opening of a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and...
Frequently Asked Questions
Frequently Asked Questions
What is Agilent Technologies Inc share price today?
plus_minus_icon
Can Indians buy Agilent Technologies Inc shares?
plus_minus_icon
How can I buy Agilent Technologies Inc shares from India?
plus_minus_icon
Can Fractional shares of Agilent Technologies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Agilent Technologies Inc stocks?
plus_minus_icon
What is today’s traded volume of Agilent Technologies Inc?
plus_minus_icon
What is today’s market capitalisation of Agilent Technologies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Agilent Technologies Inc?
plus_minus_icon
What percentage is Agilent Technologies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Agilent Technologies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$154.42
$-0.09
(-0.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ON Semiconductor Corp.
ON Semiconductor Corp.
$83.60
$-1.93 (-2.26 %)
Humana Inc.
Humana Inc.
$494.21
$13.21 (2.75 %)
Forestar Group Inc
Forestar Group Inc
$14.58
$-0.30 (-2.02 %)
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
$78.08
$-1.96 (-2.45 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
ON Semiconductor Corp.
ON Semiconductor Corp.
$83.60
$-1.93 (-2.26 %)
Humana Inc.
Humana Inc.
$494.21
$13.21 (2.75 %)
Forestar Group Inc
Forestar Group Inc
$14.58
$-0.30 (-2.02 %)
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
$78.08
$-1.96 (-2.45 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00